Gil Jin Young, Park Jeong-Nam, Lee Kyung Jin, Kang Ji-Yeon, Kim Yeong Hun, Kim Seonghun, Kim Sang-Yoon, Kwon Ohsuk, Lim Yong Taik, Kang Hyun Ah, Oh Doo-Byoung
Korea Research Institute of Bioscience and Biotechnology (KRIBB), 125 Gwahakro, Yuseong-gu, Daejeon 305-806, Republic of Korea.
Department of Life Science, College of Natural Science, Chung-Ang University, Seoul 156-756, Republic of Korea.
J Biotechnol. 2015 Jul 20;206:66-74. doi: 10.1016/j.jbiotec.2015.04.007. Epub 2015 Apr 20.
Mannosylphosphorylated N-glycans found in yeasts can be converted to those containing mannose-6-phosphate, which is a key factor for lysosomal targeting. In the traditional yeast Saccharomyces cerevisiae, both ScMNN4 and ScMNN6 genes are required for efficient mannosylphosphorylation. ScMnn4 protein has been known to be a positive regulator of ScMnn6p, a real enzyme for mannosylphosphorylation. On the other hand, YlMpo1p, a ScMnn4p homologue, mediates mannosylphosphorylation in Yarrowia lypolytica without the involvement of ScMnn6p homologues. In this study, we show that heterologous expression of YlMpo1p can perform and enhance mannosylphosphorylation in S. cerevisiae in the absence of ScMnn4p and ScMnn6p. Moreover, the level of mannosylphosphorylation of N-glycans enhanced by YlMpo1p overexpression is much higher than that with ScMnn4p overexpression, and this is highlighted further in Scmnn4- and Scmnn6-disrupted mutants. When YlMpo1p overexpression is applied to glyco-engineered S. cerevisiae in which the synthesis of immunogenic glycans is abolished, a great increase of bi-mannosylphosphorylated glycan is observed. Through an in vitro process involving the uncapping of the outer mannose residue, this bi-mannosylphosphorylated structure is changed to a bi-phosphorylated structure with high affinity for mannose-6-phosphate receptor. The superior ability of YlMpo1p to increase bi-mannosylphosphorylated glycan in yeast shows promise for the production of therapeutic enzymes with improved lysosomal targeting capability.
酵母中发现的甘露糖基磷酸化 N-聚糖可转化为含有甘露糖-6-磷酸的聚糖,这是溶酶体靶向的关键因素。在传统酵母酿酒酵母中,高效的甘露糖基磷酸化需要 ScMNN4 和 ScMNN6 基因。已知 ScMnn4 蛋白是 ScMnn6p 的正向调节因子,ScMnn6p 是甘露糖基磷酸化的真正酶。另一方面,YlMpo1p 是 ScMnn4p 的同源物,在解脂耶氏酵母中介导甘露糖基磷酸化,而不涉及 ScMnn6p 同源物。在本研究中,我们表明 YlMpo1p 的异源表达可以在没有 ScMnn4p 和 ScMnn6p 的情况下在酿酒酵母中进行并增强甘露糖基磷酸化。此外,YlMpo1p 过表达增强的 N-聚糖甘露糖基磷酸化水平远高于 ScMnn4p 过表达,这在 Scmnn4 和 Scmnn6 缺失突变体中进一步凸显。当将 YlMpo1p 过表达应用于消除了免疫原性聚糖合成的糖工程酿酒酵母时,观察到双甘露糖基磷酸化聚糖大幅增加。通过涉及去除外部甘露糖残基的体外过程,这种双甘露糖基磷酸化结构转变为对甘露糖-6-磷酸受体具有高亲和力的双磷酸化结构。YlMpo1p 在酵母中增加双甘露糖基磷酸化聚糖的卓越能力为生产具有改善的溶酶体靶向能力的治疗性酶带来了希望。